Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cytokinetics (CYTK) Long-Term Investments: 2010-2025

Historic Long-Term Investments for Cytokinetics (CYTK) over the last 10 years, with Sep 2025 value amounting to $288.8 million.

  • Cytokinetics' Long-Term Investments rose 7.30% to $288.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $288.8 million, marking a year-over-year increase of 7.30%. This contributed to the annual value of $145.1 million for FY2024, which is 257.86% up from last year.
  • Latest data reveals that Cytokinetics reported Long-Term Investments of $288.8 million as of Q3 2025, which was up 62.07% from $178.2 million recorded in Q2 2025.
  • Cytokinetics' 5-year Long-Term Investments high stood at $305.4 million for Q2 2024, and its period low was $10.7 million during Q2 2022.
  • Over the past 3 years, Cytokinetics' median Long-Term Investments value was $145.1 million (recorded in 2024), while the average stood at $134.2 million.
  • Per our database at Business Quant, Cytokinetics' Long-Term Investments plummeted by 85.52% in 2022 and then surged by 1,640.16% in 2024.
  • Over the past 5 years, Cytokinetics' Long-Term Investments (Quarterly) stood at $152.1 million in 2021, then crashed by 69.28% to $46.7 million in 2022, then fell by 13.22% to $40.5 million in 2023, then soared by 257.86% to $145.1 million in 2024, then rose by 7.30% to $288.8 million in 2025.
  • Its Long-Term Investments was $288.8 million in Q3 2025, compared to $178.2 million in Q2 2025 and $150.7 million in Q1 2025.